Siemens PETNET, Novation ink deal

Lisa Fratt | | Health Imaging | Oncology Imaging
PETNET Solutions, a wholly owned subsidiary of Siemens Medical Solutions, has signed a five-year agreement with Novation to offer its portfolio of PET radiopharmaceuticals for oncology, cardiology and neurology to healthcare facilities nationwide.

Based in Knoxville, Tenn., Siemens’ PETNET Solutions operates a network of integrated FDA-registered and state-licensed PET radiopharmaceutical manufacturing and radiopharmacy facilities, and manufactures and dispenses PET radiopharmaceuticals for hospitals, clinics and research facilities. Irving, Texas-based Novation provides sourcing services, as well as information and data services, to a wide range of U.S. healthcare providers.

Lisa Fratt

Related Content

High-intensity focused ultrasound could allow prostate cancer patients to avoid surgery
MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.